This brand name is authorized in Nigeria.
The drug ZABNAC contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
6TGQ35Z71K - DICLOFENAC DIETHYLAMINE
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
|
2
|
UNII
LAV5U5022Y - METHYL SALICYLATE
|
|
Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet. |
|
3
|
UNII
L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
|
4
|
UNII
S07O44R1ZM - CAPSAICIN
|
|
Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and erythema due to the release of vasoactive neuropeptides. |
|
5
|
Linseed oil
UNII
84XB4DV00W - LINSEED OIL
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101259 | Gel | Zabnac Gel GEL 1.16%; 5%; 3%; 0.025% 1 x 10 x 30 g (in Lami tubes) | Gel ZABNAC GEL DICLOFENAC DIETHYLAMINE BP 1.16%W/W, EQV. TO DICLOFENAC SODIUM 1.00%W/W, LINSEED OIL BP 3.00%W/W, CAPSAICIN USP 0.025%W/W, MENTHOL BP 5.00%W/W DICLOFENAC DIETHYLAMINE BP 1.16%W/W, EQV. TO DICLOFENAC SODIUM 1.00%W/W, LINSEED OIL BP 3.00%W/W, CAPSAICIN USP 0.025%W/W, MENTHOL BP 5.00%W/W A4-101259 Drugs Imported Product 1X30GX10TUBES 20-10-2023 FRESHBORN INDUSTRIES LIMITED, 45 ASHOGBON STREET IDUMOTA Lagos State 234809785 freshbornindustries@yahoo.com M/S CLAROID PHARMACEUTICAL PVT. LTD., PLOT NO. 217/P, PIRANA-KAMOD ROAD, AHMEDABAD, GUJARAT, INDIA. | 30/04/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D11AX18 | Diclofenac | D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101259 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.